Ixekizumab Improves Nail, Scalp, and Skin Response and Quality of Life Independent of Baseline Psoriasis Severity: Results From the Psoriasis in Special Areas (PSoSA) Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s418, 2024. DOI: 10.25251/skin.8.supp.418. Disponível em: https://skin.dermsquared.com/skin/article/view/3081. Acesso em: 18 may. 2025.